We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Seeks to Combat Data Falsification in Clinical Trials
FDA Seeks to Combat Data Falsification in Clinical Trials
June 21, 2006
In the wake of recent scandals over data falsification, the FDA announced its ongoing commitment to protecting human clinical research subjects at a June 21 press conference at the Drug Information Association’s annual conference in Philadelphia.